2021
DOI: 10.1016/j.jgg.2021.04.003
|View full text |Cite
|
Sign up to set email alerts
|

Genome editing in plants with MAD7 nuclease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
39
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(40 citation statements)
references
References 53 publications
0
39
1
Order By: Relevance
“…Because MAD7 "is royalty-free for both academic and commercial research and development use" (Inscripta, 2021;Price et al, 2020;Rojek et al, 2022) it serves as ideal tool for strain engineering in an industrial and commercial environment. MAD7-mediated genome engineering has been demonstrated both in eukaryotic systems including fungi (Jarczynska et al, 2021), plants (Lin et al, 2021), vertebrate and mammalian systems (Liu et al, 2020;Wierson et al, 2019), as well as in the prokaryotic organisms E. coli and Bacillus subtilis (Price et al, 2020). Previous use of MAD7 in E. coli focused on screening or nuclease engineering (Dewachter et al, 2022;Liu et al, 2019).…”
Section: Resultsmentioning
confidence: 99%
“…Because MAD7 "is royalty-free for both academic and commercial research and development use" (Inscripta, 2021;Price et al, 2020;Rojek et al, 2022) it serves as ideal tool for strain engineering in an industrial and commercial environment. MAD7-mediated genome engineering has been demonstrated both in eukaryotic systems including fungi (Jarczynska et al, 2021), plants (Lin et al, 2021), vertebrate and mammalian systems (Liu et al, 2020;Wierson et al, 2019), as well as in the prokaryotic organisms E. coli and Bacillus subtilis (Price et al, 2020). Previous use of MAD7 in E. coli focused on screening or nuclease engineering (Dewachter et al, 2022;Liu et al, 2019).…”
Section: Resultsmentioning
confidence: 99%
“…Engineered Cas MAD7-RR, MAD7-RVR, and M-AFID (MAD7-APOBEC fusion-induced deletion) increase the targeting range of MAD7 by creating predictable deletions from 5′-deaminated Cs to the MAD7-cleavage site. This new CRISPR-MAD7 system has an efficiency of up to 65.6%, as demonstrated in mutant rice and wheat plants ( Lin et al, 2021 ). MAD7 can expand the CRISPR toolbox for genome engineering due to its highly efficient target to gene disruption and insertions, different protospacer adjacent motifs, and small-guide RNA requirements ( Liu et al, 2020 ).…”
Section: Conclusion and Future Perspectivesmentioning
confidence: 92%
“…If no knock-in donor template is present, Cas12a target sites can be cut and repaired by NHEJ several times until a large deletion occurs and deletes the PAM, preventing further cleavage. Consequently, 3-30-nt deletions are frequently observed with Cas12a [10,13,[30][31][32][33], whereas Cas9 mostly induces 1-2-nt indels [13]. Although this property may favor Cas12a for gene knock-outs [19,33], preventing unwanted large deletions may be required for clinical use of Cas12a.…”
Section: Comparison Of Crispr-cas12a and Crispr-cas9mentioning
confidence: 99%